Home

Lucid Diagnostics Inc. - Common Stock (LUCD)

1.0400
+0.0300 (2.97%)
NASDAQ · Last Trade: Dec 3rd, 10:17 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
LUCD Reports Resultsfool.com
Via The Motley Fool · August 13, 2025
SAIC, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 2, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 2, 2025
Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · June 2, 2025
A Glimpse of Lucid Diagnostics's Earnings Potentialbenzinga.com
Via Benzinga · May 13, 2025
Earnings Scheduled For November 12, 2025benzinga.com
Via Benzinga · November 12, 2025
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · September 10, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · September 10, 2025
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · September 9, 2025
LUCID DIAGNOSTICS INC (NASDAQ:LUCD) Reports Q2 2025 Earnings In Line with Estimates, Narrower Loss Than Expectedchartmill.com
Lucid Diagnostics (LUCD) Q2 2025 results: Revenue $1.16M, EPS -$0.10, beating estimates. Processed 2,756 EsoGuard tests, maintains $30M+ cash. Stock up 2.26% pre-market.
Via Chartmill · August 13, 2025
Earnings Scheduled For August 13, 2025benzinga.com
Via Benzinga · August 13, 2025
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · May 23, 2025
Lucid Diagnostics: DNA Testing To Get Medicare Coverage, Driving Volumes, Says Bullish Analystbenzinga.com
A Needham analyst predicts that Lucid Diagnostics (NASDAQ: LUCD) will see a surge in testing volumes with expected Medicare reimbursement approval.
Via Benzinga · April 11, 2025
Top stock movements in today's session.chartmill.com
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · April 10, 2025
Top movers analysis in the middle of the day on 2025-04-10: top gainers and losers in today's session.chartmill.com
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · April 10, 2025
Earnings Scheduled For May 14, 2025benzinga.com
Via Benzinga · May 14, 2025
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · April 10, 2025
These stocks are gapping in today's sessionchartmill.com
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · April 10, 2025
Which stocks are moving before the opening bell on Thursday?chartmill.com
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · April 10, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · April 10, 2025
Lucid Diagnostics Stock Sinks After-Hours On Equity Raise, But Retail Dives In Anywaystocktwits.com
On Stocktwits, sentiment for the stock climbed higher within the 'extremely bullish' zone late Wednesday, while message volume rose by more than 18%.
Via Stocktwits · April 9, 2025
Curious about the stocks that are showing activity after the closing bell on Wednesday?chartmill.com
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · April 9, 2025
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · April 9, 2025
Earnings Scheduled For March 24, 2025benzinga.com
Via Benzinga · March 24, 2025
Tesla To $370? Here Are 10 Top Analyst Forecasts For Mondaybenzinga.com
Via Benzinga · December 9, 2024